# Erasca, Inc.

Type: Company (ERAS)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/erasca-inc
Canonical HTML page: https://getlegalbrief.com/entity/erasca-inc

## Timeline

- **2026-08-10**: Lead Plaintiff Deadline — Deadline for investors to move for appointment as lead plaintiff in the securities class action.
- **2026-06-15**: Securities Class Action Announced — Hagens Berman announces the filing of a federal securities class action lawsuit and begins soliciting investor clients.
- **2026-04-26**: Stock Crash and Corrective Disclosure — Erasca shares plunge 48% on news that Revolution Medicines accused the company of patent infringement and that a trial patient died a month after receiving ERAS-0015. Class period ends.
- **2026-03-12**: Alleged Misleading Statements — Erasca reportedly assured investors of ERAS-0015's IP protection and made dose-equivalence comparisons to RevMed's RMC-6236.
- **2025-01-14**: Class Period Begins — Start of the period during which Erasca allegedly made misleading statements that inflated its stock price.

## Recent coverage (1 stories)

### Erasca Hit With Securities Class Action After $2.8B Market Cap Loss
2026-06-16 14:03:48 · Sentiment: Strongly negative · Impact: 7/10 · Sources: 2

A securities fraud lawsuit alleges Erasca misled investors about IP and drug safety, triggering a 48% stock drop. Investors have until August 10, 2026 to seek lead plaintiff status.
Full story: https://getlegalbrief.com/story/erasca-securities-class-action-2-8b-loss

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.